Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Ann Neurol ; 82(6): 1004-1015, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29205472

ABSTRACT

OBJECTIVE: 3-Methylglutaconic aciduria, dystonia-deafness, hepatopathy, encephalopathy, Leigh-like syndrome (MEGDHEL) syndrome is caused by biallelic variants in SERAC1. METHODS: This multicenter study addressed the course of disease for each organ system. Metabolic, neuroradiological, and genetic findings are reported. RESULTS: Sixty-seven individuals (39 previously unreported) from 59 families were included (age range = 5 days-33.4 years, median age = 9 years). A total of 41 different SERAC1 variants were identified, including 20 that have not been reported before. With the exception of 2 families with a milder phenotype, all affected individuals showed a strikingly homogeneous phenotype and time course. Severe, reversible neonatal liver dysfunction and hypoglycemia were seen in >40% of all cases. Starting at a median age of 6 months, muscular hypotonia (91%) was seen, followed by progressive spasticity (82%, median onset = 15 months) and dystonia (82%, 18 months). The majority of affected individuals never learned to walk (68%). Seventy-nine percent suffered hearing loss, 58% never learned to speak, and nearly all had significant intellectual disability (88%). Magnetic resonance imaging features were accordingly homogenous, with bilateral basal ganglia involvement (98%); the characteristic "putaminal eye" was seen in 53%. The urinary marker 3-methylglutaconic aciduria was present in virtually all patients (98%). Supportive treatment focused on spasticity and drooling, and was effective in the individuals treated; hearing aids or cochlear implants did not improve communication skills. INTERPRETATION: MEGDHEL syndrome is a progressive deafness-dystonia syndrome with frequent and reversible neonatal liver involvement and a strikingly homogenous course of disease. Ann Neurol 2017;82:1004-1015.


Subject(s)
Carboxylic Ester Hydrolases/genetics , Deaf-Blind Disorders/diagnostic imaging , Deaf-Blind Disorders/genetics , Disease Progression , Dystonia/diagnostic imaging , Dystonia/genetics , Intellectual Disability/diagnostic imaging , Intellectual Disability/genetics , Mutation/genetics , Optic Atrophy/diagnostic imaging , Optic Atrophy/genetics , Adolescent , Adult , Amino Acid Sequence , Child , Child, Preschool , Cohort Studies , Deaf-Blind Disorders/therapy , Dystonia/therapy , Female , Humans , Infant , Infant, Newborn , Intellectual Disability/therapy , Male , Optic Atrophy/therapy , Young Adult
2.
Brain Dev ; 38(10): 954-958, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27256512

ABSTRACT

Arts syndrome is characterized by early-onset hypotonia, ataxia, intellectual disability, sensorineural hearing impairment, progressive optic atrophy, and a tendency to develop infections. Arts syndrome is an X-linked disorder caused by a loss-of-function mutation in the PRPS1 gene, which encodes phosphoribosylpyrophosphate synthetase 1. Only three families have been reported. Here, we report another family with Arts syndrome. The initial symptoms of the 1-year-old proband were hypotonia and ataxia, worsening recurrent infection-triggered muscle weakness, motor and intellectual developmental delay, and hearing loss. Both central nervous system involvement and peripheral neuropathy were demonstrated. His three maternal uncles had died before the age of 3years. A genetic analysis of PRPS1 revealed a novel missense mutation, c.367C>G (p.His123Asp). PRPS enzymatic activity was markedly reduced in the patient. His mother was supposed to be an asymptomatic carrier. Arts syndrome should be included in the differential diagnosis of infantile hypotonia and weakness aggravated by recurrent infection with a family history of X-linked inheritance.


Subject(s)
Ataxia/genetics , Deaf-Blind Disorders/genetics , Genetic Diseases, X-Linked/genetics , Mutation, Missense , Ribose-Phosphate Pyrophosphokinase/genetics , Ataxia/diagnostic imaging , Ataxia/physiopathology , Ataxia/therapy , Brain/diagnostic imaging , Deaf-Blind Disorders/diagnostic imaging , Deaf-Blind Disorders/physiopathology , Deaf-Blind Disorders/therapy , Family , Genetic Diseases, X-Linked/diagnostic imaging , Genetic Diseases, X-Linked/physiopathology , Genetic Diseases, X-Linked/therapy , Humans , Infant , Male , Neural Conduction/genetics , Pedigree
3.
JAMA Neurol ; 73(7): 880-3, 2016 Jul 01.
Article in English | MEDLINE | ID: mdl-27213952

ABSTRACT

A 37-year-old man with a history of progressive bilateral sensorineural hearing loss presented to a neuro-ophthalmology clinic with an acute left homonymous hemianopsia. In this article, we discuss the clinical approach and differential diagnosis of progressive combined vision and hearing loss and guide the reader to discover the patient's ultimate diagnosis.


Subject(s)
Deaf-Blind Disorders , Adult , Deaf-Blind Disorders/diagnostic imaging , Deaf-Blind Disorders/genetics , Deaf-Blind Disorders/metabolism , Deaf-Blind Disorders/therapy , Disease Progression , Electron Transport Complex IV/metabolism , Humans , Male , Muscle Fibers, Skeletal/metabolism , Muscle Fibers, Skeletal/pathology , Mutation/genetics , Succinate Dehydrogenase/genetics , Succinate Dehydrogenase/metabolism , Tomography Scanners, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...